While both the United States and Europe strive to provide quality cancer care, their methods differ noticeably. The US often emphasizes innovative treatments, sometimes leading to greater costs. In contrast, European systems tend to prioritize proactive care and cost-effectiveness, highlighting early screening. This can result in different patient